Results 31 to 40 of about 10,059 (251)

The seizure of illicit assets: patterns of civil forfeiture in Canada and Ireland [PDF]

, 2013
No description ...
Gallant, M Michelle, King, Colin
core   +1 more source

Efficacy of liposomal amphotericin B and anidulafungin using an antifungal lock technique (ALT) for catheter-related Candida albicans and Candida glabrata infections in an experimental model.

PLoS ONE, 2019
ObjectiveThe aims of this study were as follows. First, we sought to compare the in vitro susceptibility of liposomal amphotericin B (LAmB) and anidulafungin on Candida albicans and Candida glabrata biofilms growing on silicone discs.
Jana Basas, Marta Palau, Xavier Gomis, Benito Almirante, Joan Gavaldà   +4 more
doaj   +1 more source

Fungal infections today: size of the problem and focus on the initial cost of therapy with echinocandin

Farmeconomia: Health Economics and Therapeutic Pathways, 2010
Three candins had been approved for the treatment of invasive candidiasis (IC): caspofungin, micafungin, and anidulafungin. Different drugs are associated with different needs for dose adjustment which might affect the total cost.
Mario Venditti
doaj   +1 more source

Set of Classical PCRs for Detection of Mutations in Candida glabrata FKS Genes Linked with Echinocandin Resistance [PDF]

, 2014
Clinical echinocandin resistance among Candida glabrata strains is increasing, especially in the United States. Antifungal susceptibility testing is considered mandatory to guide therapeutic decisions.
Afeltra, Javier, Dudiuk, Catiana Beatriz, Gamarra, Maria Soledad, Garcia, Guillermo Manuel, Jimenez Ortigoza, Cristina, Leonardelli, Florencia, Perlin, David S., Vitale, Roxana Gabriela   +7 more
core   +2 more sources

In vitro synergy of echinocandins with triazoles against fluconazole-resistant Candida parapsilosis complex isolates

Journal of Global Antimicrobial Resistance, 2020
Introduction: Candida parapsilosis (C. parapsilosis) is a common non-albicans Candida species ranked as the second common cause of bloodstream infections. Azole resistance and elevated echinocandin MICs have been reported for these fungi.
Ali Ahmadi, Shahram Mahmoudi, Sassan Rezaie, Sayed Jamal Hashemi, Eric Dannaoui, Hamid Badali, Mansoureh Ghaffari, Farzad Aala, Alireza Izadi, Aida Maleki, Jacques F. Meis, Sadegh Khodavaisy   +11 more
doaj   +1 more source

Invasive pulmonary aspergillosis post extracorporeal membrane oxygenation support and literature review [PDF]

, 2014
The use of extracorporeal membrane oxygenation (ECMO) for reversible pulmonary failure in critically ill patients has increased over the last few decades.
Al-Shair, Armstrong-James, Aubron, Aubron, Bizzarro, Blot, Burket, Caillot, De Pauw, Elefanti, Estrada, Garcia, Hsu, Marasco, O’Neill, Patterson, Seyedmousavi, Upton, Walsh   +18 more
core   +3 more sources

Pharmacoeconomic analysis of the anidulafungin (EraxisR) in adult patients with invasive candidiasis

Онкогематология, 2019
Objective: to assess the economic outcomes of using anidulafungin (Eraxis®) in comparison with the recommended treatment regimens in adult patients with invasive candidiasis.Materials and methods.
S. V. Nedogoda, A. S. Salasyuk, I. N. Barykina, V. O. Smirnova   +3 more
doaj   +1 more source

Are We Ready for Nosocomial Candida auris Infections? Rapid Identification and Antifungal Resistance Detection Using MALDI-TOF Mass Spectrometry May Be the Answer

Frontiers in Cellular and Infection Microbiology, 2021
The occurrence of multidrug-resistant Candida auris isolates and the increased mortality associated with invasive infections or outbreaks due to this Candida species have been reported in many healthcare settings.
Elena De Carolis, Federica Marchionni, Marilisa La Rosa, Jacques F. Meis, Jacques F. Meis, Anuradha Chowdhary, Brunella Posteraro, Maurizio Sanguinetti, Maurizio Sanguinetti   +8 more
doaj   +1 more source

Variability in antifungal and antiviral use in hospitalized children [PDF]

, 2017
We analyzed antifungal and antiviral prescribing among high-risk children across freestanding children’s hospitals. Antifungal and antiviral days of therapy varied across hospitals.
Gerber, Jeffrey S, Goldman, Jennifer L, Hersh, Adam L, Kronman, Matthew P, Lee, Brian R, Newland, Jason G, Ross, Rachael K   +6 more
core   +2 more sources

Anidulafungin-Induced Alopecia

Annals of Pharmacotherapy, 2014
Objetive: To report a case of a woman in whom alopecia appeared after several months of treatment with anidulafungin. Case Summary: A 34-year-old woman with chronic femoral osteomyelitis with the presence of persistent suppuration, developed a Candida albicans infection, isolated in the fistula exudate cultures.
Jesus Ruiz-Ramos, E Monte-Boquet, M Salavert-Lleti, José Luis Poveda-Andrés, I. Gil-Gómez, L. Lorente-Fernández   +5 more
openaire   +4 more sources